Famotidine

( DrugBank: Famotidine / KEGG DRUG: Famotidine )

---

5 diseases

6. パーキンソン病

---

臨床試験数 : 2,586 / 薬物数 : 1,871 - (DrugBank : 354) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 205 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

46. 悪性関節リウマチ

---

臨床試験数 : 4,543 / 薬物数 : 2,251 - (DrugBank : 390) / 標的遺伝子数 : 198 - 標的パスウェイ数 : 232 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

98. 好酸球性消化管疾患

---

臨床試験数 : 214 / 薬物数 : 171 - (DrugBank : 46) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 142 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

145. ウエスト症候群

---

臨床試験数 : 49 / 薬物数 : 43 - (DrugBank : 16) / 標的遺伝子数 : 29 - 標的パスウェイ数 : 28 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries

300. IgG4関連疾患

---

臨床試験数 : 57 / 薬物数 : 52 - (DrugBank : 29) / 標的遺伝子数 : 20 - 標的パスウェイ数 : 147 

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries